Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07648251 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Furosemide vs Placebo in Severe Preeclampsia Postpartum

Study acronym: FUROPE
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This randomized, double-blind, placebo-controlled trial evaluates whether oral furosemide 40 mg, initiated 12 hours postpartum, reduces hospital length of stay compared to placebo (folic acid 5 mg) in postpartum women with severe preeclampsia. Secondary outcomes include need for rescue antihypertensive medications, weight reduction, and metabolic safety (hypokalemia, renal function). A total of 186 participants (93 per arm) will be enrolled across two hospitals in Honduras.
Trial Details
NCT Number NCT07648251
Lead Sponsor Universidad Nacional Autonoma de Honduras
Conditions
(from sponsor)		 Severe Preeclampsia
Related terms Hypertension, Pre-Eclampsia
Enrollment 186 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov